Related Experiment Video
Updated: Jan 31, 2026

A Graphical User Interface for Software-assisted Tracking of Protein Concentration in Dynamic Cellular Protrusions
Published on: July 11, 2017
mTOR: A Cellular Regulator Interface in Health and Disease
Fahd Boutouja1, Christian M Stiehm2, Harald W Platta3
1Biochemie Intrazellulärer Transportprozesse, Ruhr-Universität Bochum, 44801 Bochum, Germany. fahd.boutouja@rub.de.
The mechanistic target of Rapamycin (mTOR) pathway regulates cell growth. Inhibiting mTOR shows promise for treating cancer, autoimmune diseases, and extending lifespan.
Area of Science:
- Cellular Biology
- Molecular Biology
- Biochemistry
Background:
- The mechanistic target of Rapamycin (mTOR) is a key serine/threonine kinase.
- mTOR integrates growth signals to regulate cellular functions.
- mTOR exists in distinct signaling complexes with varied targets.
Purpose of the Study:
- To provide an overview of mTOR complex composition and function.
- To highlight the therapeutic potential of mTOR inhibitors.
- To discuss mTOR as a target for disease prevention and lifespan extension.
Main Methods:
- Literature review of mTOR signaling pathways.
- Analysis of mTOR complex structure and function.
- Synthesis of current research on mTOR inhibitors.
Main Results:
- mTOR signaling is crucial for cell growth and metabolism.
- mTOR inhibitors are under development for various diseases.
- Targeted mTOR inhibition offers therapeutic possibilities.
Conclusions:
- Understanding mTOR complexes is vital for developing targeted therapies.
- Selective mTOR inhibition may prevent severe diseases.
- mTOR pathway modulation holds potential for life extension.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Protein-protein Interfaces
Protein-Protein Interfaces
GTPases and their Regulation
Large G-proteins,...
PI3K/mTOR/AKT Signaling Pathway
Master Transcription Regulators

